SCN4A Gene Potassium-aggravated myotonia Genetic Test
Cost: 4400.0 AED
Test Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for SCN4A Gene Potassium-aggravated myotonia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN4A Gene Potassium-aggravated myotonia.
Test Details:
The SCN4A gene is responsible for encoding a protein called the sodium channel voltage-gated type IV alpha subunit. Mutations in this gene can lead to a condition called potassium-aggravated myotonia. Potassium-aggravated myotonia is a type of muscle disorder characterized by muscle stiffness and delayed relaxation after contraction. This condition is worsened by high levels of potassium in the blood, which can be triggered by factors such as exercise, stress, or certain medications.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes. In the case of potassium-aggravated myotonia, NGS genetic testing can be used to identify mutations in the SCN4A gene that may be responsible for the condition. By identifying these mutations, NGS genetic testing can help with the diagnosis of potassium-aggravated myotonia and provide important information for genetic counseling and treatment decisions. It can also be used for carrier testing in individuals with a family history of the condition.
Overall, the SCN4A gene potassium-aggravated myotonia NGS genetic test is a valuable tool in the diagnosis and management of this muscle disorder.
| Test Name | SCN4A Gene Potassium-aggravated myotonia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SCN4A Gene Potassium-aggravated myotonia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN4A Gene Potassium-aggravated myotonia |
| Test Details |
The SCN4A gene is responsible for encoding a protein called the sodium channel voltage-gated type IV alpha subunit. Mutations in this gene can lead to a condition called potassium-aggravated myotonia. Potassium-aggravated myotonia is a type of muscle disorder characterized by muscle stiffness and delayed relaxation after contraction. This condition is worsened by high levels of potassium in the blood, which can be triggered by factors such as exercise, stress, or certain medications. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes. In the case of potassium-aggravated myotonia, NGS genetic testing can be used to identify mutations in the SCN4A gene that may be responsible for the condition. By identifying these mutations, NGS genetic testing can help with the diagnosis of potassium-aggravated myotonia and provide important information for genetic counseling and treatment decisions. It can also be used for carrier testing in individuals with a family history of the condition. Overall, the SCN4A gene potassium-aggravated myotonia NGS genetic test is a valuable tool in the diagnosis and management of this muscle disorder. |
